Raphael Pharmaceuticals Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Public

  • Stock Symbol
  • RAPH

Stock Symbol

  • Share Price
  • $1.00
  • (As of Tuesday Closing)

Raphael Pharmaceuticals General Information

Description

Raphael Pharmaceutical Inc is a pharmaceutical drug research and development company focused on the discovery and clinical development of life-improving drug therapies based on cannabinoids, including cannabidiol, or CBD oil.

Contact Information

Website
www.raphaelpharmaceutical.com
Formerly Known As
Easy Energy
Ownership Status
Publicly Held
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • Andrei Saharov 9
  • 4 Lui Paster
  • Haifa 6803605
  • Israel
+972
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
PINX
Vertical(s)
Cannabis, Life Sciences, Oncology
Corporate Office
  • Andrei Saharov 9
  • 4 Lui Paster
  • Haifa 6803605
  • Israel
+972

Raphael Pharmaceuticals Timeline

2022202320242025
Financing Round

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Raphael Pharmaceuticals Stock Performance

As of 18-Feb-2025, Raphael Pharmaceuticals’s stock price is $1.00. Its current market cap is $18.7M with 18.7M shares.

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.00 $1.00 $0.23 - $1.65 $18.7M 18.7M 1.32K -$0.04

Raphael Pharmaceuticals Financials Summary

As of 30-Sep-2024, Raphael Pharmaceuticals has a trailing 12-month revenue of null.

In Thousands,
USD 		TTM 30-Sep-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 17,803
Revenue 0 0 0 0
EBITDA (1,002) (1,284) (3,358) (1,629)
Net Income (1,002) (1,284) (3,358) (1,624)
Total Assets 51 339 333 422
Total Debt 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Raphael Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Raphael Pharmaceuticals‘s full profile, request access.

Request a free trial

Raphael Pharmaceuticals FAQs

  • When was Raphael Pharmaceuticals founded?

    Raphael Pharmaceuticals was founded in 2018.

  • Where is Raphael Pharmaceuticals headquartered?

    Raphael Pharmaceuticals is headquartered in Haifa, Israel.

  • What industry is Raphael Pharmaceuticals in?

    Raphael Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Raphael Pharmaceuticals a private or public company?

    Raphael Pharmaceuticals is a Public company.

  • What is Raphael Pharmaceuticals’s stock symbol?

    The ticker symbol for Raphael Pharmaceuticals is RAPH.

  • What is the current stock price of Raphael Pharmaceuticals?

    As of 18-Feb-2025 the stock price of Raphael Pharmaceuticals is $1.00.

  • What is the current market cap of Raphael Pharmaceuticals?

    The current market capitalization of Raphael Pharmaceuticals is $18.7M.

  • What is Raphael Pharmaceuticals’s annual earnings per share (EPS)?

    Raphael Pharmaceuticals’s EPS for 12 months was -$0.04.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »